JG
GNMK

Jefferies Group’s GenMark Diagnostics, Inc GNMK Stock Holding History

Jefferies Group’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-21,652
Closed -$154K – 3017
2019
Q1 		$154K Sell
21,652
-3,212
-13% -$21.2K ﹤0.01% 2018
2018
Q4 		$121K Buy
24,864
+10,258
+70% +$53.4K ﹤0.01% 1939
2018
Q3 		$107K Sell
14,606
-13,333
-48% -$97.8K ﹤0.01% 2212
2018
Q2 		$178K Buy
+27,939
New +$185K ﹤0.01% 2054
2015
Q1 		– Sell
-191,106
Closed -$2.6M – 2490
2014
Q4 		$2.6M Buy
+191,106
New +$2.14M 0.02% 623

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jefferies Group's GNMK Position: Q2 2019 in Review

Jefferies Group sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2019, closing a stake of 21,652 shares — an estimated $154K sold.

Jefferies Group first reported a position in GNMK in Q4 2014 and held it in 5 quarters. The position peaked at $2.6M in Q4 2014. 106 funds tracked by Wall St. Rank hold GNMK as of Q2 2019.

  • Jefferies Group reported no remaining GenMark Diagnostics, Inc position as of Q2 2019 after selling out during the quarter.
  • Jefferies Group sold 21,652 GenMark Diagnostics, Inc shares in Q2 2019, an estimated $154K.
  • Jefferies Group first reported a position in GenMark Diagnostics, Inc in Q4 2014 and held it in 5 quarters.
  • Jefferies Group's GenMark Diagnostics, Inc position peaked at $2.6M in Q4 2014.
  • 106 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2019.

Based on Jefferies Group's 13F filing for Q2 2019, filed 14 Aug 2019.